Filing Details
- Accession Number:
- 0001493152-23-017842
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-16 18:00:10
- Reporting Period:
- 2023-05-12
- Accepted Time:
- 2023-05-16 18:00:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1862150 | Cingulate Inc. | CING | Pharmaceutical Preparations (2834) | 863825535 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1883523 | L. Jennifer Callahan | 1901 W. 47Th Place Kansas City KS 66205 | Corporate Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-05-12 | 4,000 | $1.08 | 38,508 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2023-05-15 | 2,000 | $1.01 | 40,508 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrant to Purchase Common Stock | Acquisiton | 2023-05-12 | 1,030 | $0.11 | 1,030 | $6.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 19,530 | 2021-12-10 | 2026-12-10 | No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.0097 to $1.01 per share, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
- The price reported in Column 4 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.1076 to $0.11 per warrant, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants purchased at each separate price within the ranges set forth herein.
Billionaire Hedge Funds
